---
title: "Definium Therapeutics, Inc. (DFTX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/DFTX.US.md"
symbol: "DFTX.US"
name: "Definium Therapeutics, Inc."
industry: "制藥"
---

# Definium Therapeutics, Inc. (DFTX.US)

| Item | Detail |
|------|--------|
| Industry | 制藥 |
| Location | 美股市場 |
| Website | [definiumtx.com](https://definiumtx.com) |

## Company Profile

Definium Therapeutics, Inc.是一家臨床階段的生物制藥公司，開發用于治療大腦健康障礙的新產品。該公司的主要產品候選包括 MM120，目前正在進行針對廣泛性焦慮障礙和注意力缺陷多動障礙的三期臨床試驗；以及 DT402，這是一種 3,4-亞甲基二氧基甲基苯丙胺的 R-對映體，目前正在進行針對自閉症譜系障礙核心症狀的二期臨床試驗。該公司之前被稱為 Mind Medicine (MindMed) Inc.，並更名為 Definium Therapeutics, Inc

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -10.23 | 185/257 | - | - | - |
| PB | 13.16 | 175/257 | 13.10 | 12.80 | 12.26 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-23T05:00:00.000Z

Total Analysts: **15**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 12 | 80% |
| Overweight | 3 | 20% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 17.45 |
| Highest Target | 61.00 |
| Lowest Target | 18.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/DFTX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/DFTX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/DFTX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.